This 50% SP haircut over the past 5 months IMO is the combination of many factors , one being COVID 19 issue, selling for safer investments, could be also financing concerns as the warrant extension program did not attract any interest, which was a huge surprise probably to mangement , then you have ORISTAR hedge fund and others playing games with the SP by maybe trying to drive it down so they can convert their debenture at a much lower cost base .

IMO the science and the FDA BTD will speak for itself even if a a deal does not happen to move forward with BETONMACE2 , a deal will happen if BETONMACE2 is a successful, how many kick at the cans will RVX get, they have all the most important data now to get the best chance for FDA approval for Apabetalone